# Wix.com timeline

entity: /record/wix.md  
id: ent_wix  


## undated

- undated | ticker | WIX | valid | [clm_78B785B25B6A](/claim/clm_78B785B25B6A.md)
- undated to 2013-05-30 | registrant_name | Wix.com Ltd. | superseded | [clm_7E286A5EF58E](/claim/clm_7E286A5EF58E.md)
- undated | sic_industry | Services-Computer Programming, Data Processing, Etc. (7370) | valid | [clm_ADD9C08F16EE](/claim/clm_ADD9C08F16EE.md)
- undated | fiscal_year_end | 12-31 | valid | [clm_BED76D756602](/claim/clm_BED76D756602.md)
- undated | cik | 0001576789 | valid | [clm_E23B712F7902](/claim/clm_E23B712F7902.md)
- undated | state_of_incorporation | L3 | valid | [clm_E8E82C109314](/claim/clm_E8E82C109314.md)
- undated | industry | website builder | unverified | [clm_6906F9604C4F](/claim/clm_6906F9604C4F.md)
- undated | website | https://wix.com/ | unverified | [clm_7B16FB963AEF](/claim/clm_7B16FB963AEF.md)
- undated | country | United States | unverified | [clm_918572E5DFED](/claim/clm_918572E5DFED.md)
- undated | legal_form | joint-stock company | unverified | [clm_C5FEEC8236EA](/claim/clm_C5FEEC8236EA.md)
- undated | industry | e-commerce | unverified | [clm_D5FBA2912126](/claim/clm_D5FBA2912126.md)

## 2007

- 2007-06-05 | x_username | Wix | unverified | [clm_41FE72106E2B](/claim/clm_41FE72106E2B.md)

## 2010

- 2010-08-04 | x_username | WixPartners | unverified | [clm_BAAE136A99E7](/claim/clm_BAAE136A99E7.md)
- 2010-12-31 to 2011-12-31 | cash_and_equivalents | 4,501,000 United States dollar | superseded | [clm_0038C444F875](/claim/clm_0038C444F875.md)
- 2010-12-31 to 2011-12-31 | total_equity | -16,000 United States dollar | superseded | [clm_6CC093642454](/claim/clm_6CC093642454.md)

## 2011

- 2011-12-31 to 2012-12-31 | research_and_development | 14,746,000 United States dollar | superseded | [clm_5664B9AA69DF](/claim/clm_5664B9AA69DF.md)
- 2011-12-31 to 2012-12-31 | net_income | -22,740,000 United States dollar | superseded | [clm_59358C3D2DA2](/claim/clm_59358C3D2DA2.md)
- 2011-12-31 to 2012-12-31 | cash_and_equivalents | 10,374,000 United States dollar | superseded | [clm_AD1CE6A6518C](/claim/clm_AD1CE6A6518C.md)
- 2011-12-31 to 2012-12-31 | total_equity | 3,086,000 United States dollar | superseded | [clm_D658CBD62811](/claim/clm_D658CBD62811.md)
- 2011-12-31 to 2012-12-31 | revenue | 24,600,000 United States dollar | superseded | [clm_EB9433E1D5AE](/claim/clm_EB9433E1D5AE.md)
- 2011-12-31 to 2012-12-31 | operating_income | -22,360,000 United States dollar | superseded | [clm_F2797EBC6994](/claim/clm_F2797EBC6994.md)

## 2012

- 2012-12-31 to 2013-12-31 | total_equity | -10,571,000 United States dollar | superseded | [clm_794C648B2BBA](/claim/clm_794C648B2BBA.md)
- 2012-12-31 to 2013-12-31 | revenue | 43,676,000 United States dollar | superseded | [clm_A47145887868](/claim/clm_A47145887868.md)
- 2012-12-31 to 2013-12-31 | net_income | -14,972,000 United States dollar | superseded | [clm_AB56B8006DCE](/claim/clm_AB56B8006DCE.md)
- 2012-12-31 to 2013-12-31 | research_and_development | 16,782,000 United States dollar | superseded | [clm_BDB303BA44B7](/claim/clm_BDB303BA44B7.md)
- 2012-12-31 to 2013-12-31 | cash_and_equivalents | 7,510,000 United States dollar | superseded | [clm_D1E1AE8084B7](/claim/clm_D1E1AE8084B7.md)
- 2012-12-31 to 2013-12-31 | operating_income | -14,961,000 United States dollar | superseded | [clm_F078251408AB](/claim/clm_F078251408AB.md)
- 2012-12-31 to 2013-12-31 | total_assets | 16,055,000 United States dollar | superseded | [clm_FB6574D552E4](/claim/clm_FB6574D552E4.md)

## 2013

- 2013-05-30 to 2013-07-15 | registrant_name | Wixpress Ltd. | superseded | [clm_5CA04D781125](/claim/clm_5CA04D781125.md)
- 2013-11-06 | listed_on | Nasdaq | valid | [clm_4F028DD3FAAD](/claim/clm_4F028DD3FAAD.md)
- 2013-12-31 to 2014-12-31 | revenue | 80,473,000 United States dollar | superseded | [clm_47C5620C8842](/claim/clm_47C5620C8842.md)
- 2013-12-31 to 2014-12-31 | total_assets | 115,355,000 United States dollar | superseded | [clm_731883FF282D](/claim/clm_731883FF282D.md)
- 2013-12-31 to 2014-12-31 | total_equity | 62,296,000 United States dollar | superseded | [clm_9F8602D67EC2](/claim/clm_9F8602D67EC2.md)
- 2013-12-31 to 2014-12-31 | operating_income | -26,527,000 United States dollar | superseded | [clm_A35C6652268F](/claim/clm_A35C6652268F.md)
- 2013-12-31 to 2014-12-31 | net_income | -28,720,000 United States dollar | superseded | [clm_C586DAB0FA26](/claim/clm_C586DAB0FA26.md)
- 2013-12-31 to 2014-12-31 | research_and_development | 29,660,000 United States dollar | superseded | [clm_E097220702C9](/claim/clm_E097220702C9.md)
- 2013-12-31 to 2014-12-31 | shares_outstanding | 37,493,217 shares | superseded | [clm_E35D230E2B24](/claim/clm_E35D230E2B24.md)
- 2013-12-31 to 2014-12-31 | cash_and_equivalents | 101,258,000 United States dollar | superseded | [clm_EE9EA007C049](/claim/clm_EE9EA007C049.md)

## 2014

- 2014-11-20 | x_username | WixEng | unverified | [clm_DB89803DD3B8](/claim/clm_DB89803DD3B8.md)
- 2014-12-31 to 2015-12-31 | total_equity | 18,650,000 United States dollar | superseded | [clm_066A58BA488E](/claim/clm_066A58BA488E.md)
- 2014-12-31 to 2015-12-31 | cash_and_equivalents | 40,200,000 United States dollar | superseded | [clm_0F60CE10D53E](/claim/clm_0F60CE10D53E.md)
- 2014-12-31 to 2015-12-31 | operating_income | -55,644,000 United States dollar | superseded | [clm_44FA617A83D4](/claim/clm_44FA617A83D4.md)
- 2014-12-31 to 2015-12-31 | net_income | -56,566,000 United States dollar | superseded | [clm_4971A41AE4D8](/claim/clm_4971A41AE4D8.md)
- 2014-12-31 to 2015-12-31 | shares_outstanding | 38,419,193 shares | superseded | [clm_5061BACCD93F](/claim/clm_5061BACCD93F.md)
- 2014-12-31 to 2015-12-31 | total_assets | 118,422,000 United States dollar | superseded | [clm_5F960A25C4D7](/claim/clm_5F960A25C4D7.md)
- 2014-12-31 to 2015-12-31 | revenue | 141,841,000 United States dollar | superseded | [clm_7BB4712BB921](/claim/clm_7BB4712BB921.md)
- 2014-12-31 to 2015-12-31 | research_and_development | 57,832,000 United States dollar | superseded | [clm_FDBAAF068D5D](/claim/clm_FDBAAF068D5D.md)

## 2015

- 2015-12-31 to 2016-12-31 | total_assets | 149,433,000 United States dollar | superseded | [clm_0762B2A8C3BE](/claim/clm_0762B2A8C3BE.md)
- 2015-12-31 to 2016-12-31 | research_and_development | 77,647,000 United States dollar | superseded | [clm_1FF7772DFF81](/claim/clm_1FF7772DFF81.md)
- 2015-12-31 to 2016-12-31 | revenue | 203,518,000 United States dollar | superseded | [clm_37FEB5216EE3](/claim/clm_37FEB5216EE3.md)
- 2015-12-31 to 2016-12-31 | operating_income | -48,635,000 United States dollar | superseded | [clm_3B671B3ABFD0](/claim/clm_3B671B3ABFD0.md)
- 2015-12-31 to 2016-12-31 | total_equity | -3,805,000 United States dollar | superseded | [clm_4DA4C2F1217C](/claim/clm_4DA4C2F1217C.md)
- 2015-12-31 to 2016-12-31 | shares_outstanding | 40,272,846 shares | superseded | [clm_6EC2F77710BD](/claim/clm_6EC2F77710BD.md)
- 2015-12-31 to 2016-12-31 | cash_and_equivalents | 39,226,000 United States dollar | superseded | [clm_7E306F12586E](/claim/clm_7E306F12586E.md)
- 2015-12-31 to 2016-12-31 | net_income | -51,334,000 United States dollar | superseded | [clm_8DAA02E8E000](/claim/clm_8DAA02E8E000.md)

## 2016

- 2016-06-20 | x_username | WixHelp | unverified | [clm_760EFDCD7A73](/claim/clm_760EFDCD7A73.md)
- 2016-12-31 to 2017-12-31 | net_income | -46,896,000 United States dollar | superseded | [clm_220EB37DF7C7](/claim/clm_220EB37DF7C7.md)
- 2016-12-31 to 2017-12-31 | total_assets | 214,684,000 United States dollar | superseded | [clm_3CEDE2AB23C6](/claim/clm_3CEDE2AB23C6.md)
- 2016-12-31 to 2017-12-31 | research_and_development | 105,368,000 United States dollar | superseded | [clm_7C476447FDEE](/claim/clm_7C476447FDEE.md)
- 2016-12-31 to 2017-12-31 | shares_outstanding | 44,297,761 shares | superseded | [clm_914FF5452D27](/claim/clm_914FF5452D27.md)
- 2016-12-31 to 2017-12-31 | operating_income | -44,032,000 United States dollar | superseded | [clm_AAA2F5AAD91F](/claim/clm_AAA2F5AAD91F.md)
- 2016-12-31 to 2017-12-31 | cash_and_equivalents | 93,064,000 United States dollar | superseded | [clm_B7140604E944](/claim/clm_B7140604E944.md)
- 2016-12-31 to 2017-12-31 | revenue | 290,103,000 United States dollar | superseded | [clm_CE41C8D7CD68](/claim/clm_CE41C8D7CD68.md)
- 2016-12-31 to 2017-12-31 | total_equity | -2,469,000 United States dollar | superseded | [clm_EF38737CFB6A](/claim/clm_EF38737CFB6A.md)

## 2017

- 2017-12-31 to 2018-12-31 | cash_and_equivalents | 85,230,000 United States dollar | superseded | [clm_05660727093A](/claim/clm_05660727093A.md)
- 2017-12-31 to 2018-12-31 | revenue | 425,636,000 United States dollar | superseded | [clm_09974230BC0C](/claim/clm_09974230BC0C.md)
- 2017-12-31 to 2018-12-31 | operating_income | -50,011,000 United States dollar | superseded | [clm_0E3D276F3AB1](/claim/clm_0E3D276F3AB1.md)
- 2017-12-31 to 2018-12-31 | total_assets | 330,013,000 United States dollar | superseded | [clm_0E9BAB3886BA](/claim/clm_0E9BAB3886BA.md)
- 2017-12-31 to 2018-12-31 | shares_outstanding | 46,453,583 shares | superseded | [clm_1C4E99736C22](/claim/clm_1C4E99736C22.md)
- 2017-12-31 to 2018-12-31 | net_income | -56,273,000 United States dollar | superseded | [clm_4B5ED58218DC](/claim/clm_4B5ED58218DC.md)
- 2017-12-31 to 2018-12-31 | research_and_development | 153,635,000 United States dollar | superseded | [clm_AAA0B05DCBB4](/claim/clm_AAA0B05DCBB4.md)
- 2017-12-31 to 2018-12-31 | total_equity | 11,320,000 United States dollar | superseded | [clm_BB020BC7E592](/claim/clm_BB020BC7E592.md)

## 2018

- 2018-12-31 to 2019-12-31 | revenue | 603,704,000 United States dollar | superseded | [clm_06F4FA1939FD](/claim/clm_06F4FA1939FD.md)
- 2018-12-31 to 2019-12-31 | shares_outstanding | 49,269,626 shares | superseded | [clm_1DE9B444BAE2](/claim/clm_1DE9B444BAE2.md)
- 2018-12-31 to 2019-12-31 | operating_income | -30,630,000 United States dollar | superseded | [clm_7DF80FC6AF0D](/claim/clm_7DF80FC6AF0D.md)
- 2018-12-31 to 2019-12-31 | total_assets | 844,750,000 United States dollar | superseded | [clm_7E6F4DB08F71](/claim/clm_7E6F4DB08F71.md)
- 2018-12-31 to 2019-12-31 | cash_and_equivalents | 331,057,000 United States dollar | superseded | [clm_983205D2967E](/claim/clm_983205D2967E.md)
- 2018-12-31 to 2019-12-31 | net_income | -37,120,000 United States dollar | superseded | [clm_A58FA09BA3EF](/claim/clm_A58FA09BA3EF.md)
- 2018-12-31 to 2019-12-31 | total_equity | 152,265,000 United States dollar | superseded | [clm_BB6A22B60459](/claim/clm_BB6A22B60459.md)
- 2018-12-31 to 2019-12-31 | research_and_development | 198,912,000 United States dollar | superseded | [clm_D1F045D330D4](/claim/clm_D1F045D330D4.md)

## 2019

- 2019-12-31 to 2020-12-31 | operating_income | -80,250,000 United States dollar | superseded | [clm_0002C07AB096](/claim/clm_0002C07AB096.md)
- 2019-12-31 to 2020-12-31 | total_equity | 207,749,000 United States dollar | superseded | [clm_004ACC9E3F0B](/claim/clm_004ACC9E3F0B.md)
- 2019-12-31 to 2020-12-31 | revenue | 761,088,000 United States dollar | superseded | [clm_3C2F0FE02C2B](/claim/clm_3C2F0FE02C2B.md)
- 2019-12-31 to 2020-12-31 | shares_outstanding | 51,525,919 shares | superseded | [clm_7C09FAC2CA03](/claim/clm_7C09FAC2CA03.md)
- 2019-12-31 to 2020-12-31 | cash_and_equivalents | 268,103,000 United States dollar | superseded | [clm_92AFE512DF47](/claim/clm_92AFE512DF47.md)
- 2019-12-31 to 2020-12-31 | research_and_development | 250,791,000 United States dollar | superseded | [clm_9BB171471CCC](/claim/clm_9BB171471CCC.md)
- 2019-12-31 to 2020-12-31 | total_assets | 1,099,667,000 United States dollar | superseded | [clm_BF9032051A97](/claim/clm_BF9032051A97.md)
- 2019-12-31 to 2020-12-31 | net_income | -86,414,000 United States dollar | superseded | [clm_C54FD2229965](/claim/clm_C54FD2229965.md)

## 2020

- 2020-02-01 | x_username | WixStudio | unverified | [clm_D9EB573E309B](/claim/clm_D9EB573E309B.md)
- 2020-12-31 to 2021-12-31 | operating_income | -197,342,000 United States dollar | superseded | [clm_49A2FF532690](/claim/clm_49A2FF532690.md)
- 2020-12-31 to 2021-12-31 | total_assets | 1,893,526,000 United States dollar | superseded | [clm_4A445EFF372A](/claim/clm_4A445EFF372A.md)
- 2020-12-31 to 2021-12-31 | cash_and_equivalents | 168,858,000 United States dollar | superseded | [clm_4A4CAA753B0C](/claim/clm_4A4CAA753B0C.md)
- 2020-12-31 to 2021-12-31 | net_income | -165,154,000 United States dollar | superseded | [clm_4B11160F6D9F](/claim/clm_4B11160F6D9F.md)
- 2020-12-31 to 2021-12-31 | revenue | 988,760,000 United States dollar | superseded | [clm_8480E855B9D4](/claim/clm_8480E855B9D4.md)
- 2020-12-31 to 2021-12-31 | total_equity | 301,708,000 United States dollar | superseded | [clm_B055CF4B3157](/claim/clm_B055CF4B3157.md)
- 2020-12-31 to 2021-12-31 | shares_outstanding | 56,027,758 shares | superseded | [clm_E7110A727464](/claim/clm_E7110A727464.md)
- 2020-12-31 to 2021-12-31 | research_and_development | 320,278,000 United States dollar | superseded | [clm_F948B70B7AB6](/claim/clm_F948B70B7AB6.md)

## 2021

- 2021-12-31 to 2022-12-31 | net_income | -117,209,000 United States dollar | superseded | [clm_43B418D4886B](/claim/clm_43B418D4886B.md)
- 2021-12-31 to 2022-12-31 | cash_and_equivalents | 451,355,000 United States dollar | superseded | [clm_5097F8E05FE6](/claim/clm_5097F8E05FE6.md)
- 2021-12-31 to 2022-12-31 | shares_outstanding | 57,254,189 shares | superseded | [clm_90C907C40937](/claim/clm_90C907C40937.md)
- 2021-12-31 to 2022-12-31 | operating_income | -325,534,000 United States dollar | superseded | [clm_90CA74834D71](/claim/clm_90CA74834D71.md)
- 2021-12-31 to 2022-12-31 | research_and_development | 424,937,000 United States dollar | superseded | [clm_C8136234BF6D](/claim/clm_C8136234BF6D.md)
- 2021-12-31 to 2022-12-31 | total_assets | 2,059,787,000 United States dollar | superseded | [clm_CE7520A62979](/claim/clm_CE7520A62979.md)
- 2021-12-31 to 2022-12-31 | total_equity | 145,715,000 United States dollar | superseded | [clm_CF1B22CD3697](/claim/clm_CF1B22CD3697.md)
- 2021-12-31 to 2022-12-31 | revenue | 1,269,657,000 United States dollar | superseded | [clm_D467E33CF7F0](/claim/clm_D467E33CF7F0.md)

## 2022

- 2022-02-25 | x_username | DevsOnWix | unverified | [clm_98541CDB49E1](/claim/clm_98541CDB49E1.md)
- 2022-12-31 to 2023-12-31 | shares_outstanding | 56,305,462 shares | superseded | [clm_11FDE7C7779E](/claim/clm_11FDE7C7779E.md)
- 2022-12-31 to 2023-12-31 | total_assets | 1,758,367,000 United States dollar | superseded | [clm_5AD504A2AD0D](/claim/clm_5AD504A2AD0D.md)
- 2022-12-31 to 2023-12-31 | cash_and_equivalents | 244,686,000 United States dollar | superseded | [clm_90C215B6BF90](/claim/clm_90C215B6BF90.md)
- 2022-12-31 to 2023-12-31 | revenue | 1,387,666,000 United States dollar | superseded | [clm_9E0932FC85E7](/claim/clm_9E0932FC85E7.md)
- 2022-12-31 to 2023-12-31 | research_and_development | 482,861,000 United States dollar | superseded | [clm_AB64867C5145](/claim/clm_AB64867C5145.md)
- 2022-12-31 to 2023-12-31 | net_income | -424,863,000 United States dollar | superseded | [clm_F3008B106C19](/claim/clm_F3008B106C19.md)
- 2022-12-31 to 2023-12-31 | total_equity | -263,242,000 United States dollar | superseded | [clm_F8298DA128BA](/claim/clm_F8298DA128BA.md)
- 2022-12-31 to 2023-12-31 | operating_income | -285,353,000 United States dollar | superseded | [clm_FB487419C6B2](/claim/clm_FB487419C6B2.md)

## 2023

- 2023-12-31 to 2024-12-31 | cash_and_equivalents | 609,622,000 United States dollar | superseded | [clm_2C4B9D6B875F](/claim/clm_2C4B9D6B875F.md)
- 2023-12-31 to 2024-12-31 | shares_outstanding | 57,172,595 shares | superseded | [clm_32202F291EE2](/claim/clm_32202F291EE2.md)
- 2023-12-31 to 2024-12-31 | revenue | 1,561,665,000 United States dollar | superseded | [clm_65E24EEFF18A](/claim/clm_65E24EEFF18A.md)
- 2023-12-31 to 2024-12-31 | operating_income | -24,380,000 United States dollar | superseded | [clm_6C7970158A53](/claim/clm_6C7970158A53.md)
- 2023-12-31 to 2024-12-31 | research_and_development | 481,293,000 United States dollar | superseded | [clm_70FE6206ABBC](/claim/clm_70FE6206ABBC.md)
- 2023-12-31 to 2024-12-31 | total_equity | -54,485,000 United States dollar | superseded | [clm_83B6E14DC4C2](/claim/clm_83B6E14DC4C2.md)
- 2023-12-31 to 2024-12-31 | total_assets | 1,804,136,000 United States dollar | superseded | [clm_E291D91FD4A1](/claim/clm_E291D91FD4A1.md)
- 2023-12-31 to 2024-12-31 | net_income | 33,137,000 United States dollar | superseded | [clm_F38B13DA0293](/claim/clm_F38B13DA0293.md)

## 2024

- 2024-03-01 to 2024-03-01 | employees | 5,929 | superseded | [clm_0896C80246A7](/claim/clm_0896C80246A7.md)
- 2024-12-31 to 2025-12-31 | shares_outstanding | 56,107,932 shares | superseded | [clm_0AE1C2E35F41](/claim/clm_0AE1C2E35F41.md)
- 2024-12-31 to 2025-12-31 | research_and_development | 495,281,000 United States dollar | superseded | [clm_1B707CCD5010](/claim/clm_1B707CCD5010.md)
- 2024-12-31 to 2025-12-31 | net_income | 138,322,000 United States dollar | superseded | [clm_2F26119B9FD9](/claim/clm_2F26119B9FD9.md)
- 2024-12-31 to 2025-12-31 | revenue | 1,760,650,000 United States dollar | superseded | [clm_53517272BEB7](/claim/clm_53517272BEB7.md)
- 2024-12-31 to 2025-12-31 | total_equity | -78,786,000 United States dollar | superseded | [clm_57FDEFDC6D96](/claim/clm_57FDEFDC6D96.md)
- 2024-12-31 to 2025-12-31 | total_assets | 1,913,042,000 United States dollar | superseded | [clm_5F0048DA35B0](/claim/clm_5F0048DA35B0.md)
- 2024-12-31 to 2025-12-31 | cash_and_equivalents | 660,939,000 United States dollar | superseded | [clm_DD6D736A8EBF](/claim/clm_DD6D736A8EBF.md)
- 2024-12-31 to 2025-12-31 | operating_income | 100,141,000 United States dollar | superseded | [clm_E6E616C19944](/claim/clm_E6E616C19944.md)

## 2025

- 2025-12-31 | total_equity | -366,002,000 United States dollar | valid | [clm_04EE8D9BC4BF](/claim/clm_04EE8D9BC4BF.md)
- 2025-12-31 | revenue | 1,993,044,000 United States dollar | valid | [clm_19CE84B43803](/claim/clm_19CE84B43803.md)
- 2025-12-31 | research_and_development | 645,501,000 United States dollar | valid | [clm_57728670FF4D](/claim/clm_57728670FF4D.md)
- 2025-12-31 | operating_income | 1,752,000 United States dollar | valid | [clm_720DC04F59E4](/claim/clm_720DC04F59E4.md)
- 2025-12-31 | employees | 4,622 | valid | [clm_79D7E1D06CA6](/claim/clm_79D7E1D06CA6.md)
- 2025-12-31 | total_assets | 2,610,974,000 United States dollar | valid | [clm_957B86A78EF0](/claim/clm_957B86A78EF0.md)
- 2025-12-31 | net_income | 50,646,000 United States dollar | valid | [clm_96C512CA5B77](/claim/clm_96C512CA5B77.md)
- 2025-12-31 | cash_and_equivalents | 311,356,000 United States dollar | valid | [clm_AEE69ED0373B](/claim/clm_AEE69ED0373B.md)
- 2025-12-31 | shares_outstanding | 54,989,523 shares | valid | [clm_EDB55A95EB98](/claim/clm_EDB55A95EB98.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.